THERMI, AN ALMIRALL COMPANY

About Thermi®

The Thermi flagship product is the ThermiRF®, Temperature Controlled Radiofrequency Generator System, is indicated in the EU for ablation of nerve tissue for pain management and electrocoagulation of soft tissue for vulvovaginal laxity. ThermiRF®, is an advanced technology using finely controlled thermal energy. It is a multi-use platform which uses proprietary hand pieces designed for specific medical applications and promotes increased patient safety and clinical effectiveness, while providing versatile solutions for physicians serving the aesthetic market.

The Thermi250® also employs temperature-controlled radiofrequency using a specially designed thermistor’s regulated hand piece, which delivers precise heating to the skin’s surface. 

For more information, please visit Thermi.com

About Almirall

Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying Science to provide medical solutions to patients & future generations. Our efforts are focused on fighting against skin health diseases and helping people feel and look their best. We support healthcare professionals in its continuous improvement, bringing our innovative solutions where they are needed.

The company, founded in 1943 and with headquarters in Barcelona, is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key element of value creation to society according to its commitment with its major shareholders and its decision to help others, to understand their challenges and to use Science to provide them with solutions for real life. Total revenue in 2016 was 859.3 million euros and more than 2,000 employees are devoted to Science.

For more information, please visit Almirall.com or linkedin.com/company/almirall